UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Aconitate Decarboxylase 1 Deficiency Exacerbates Mouse Colitis Induced by Dextran Sodium Sulfate

International journal of molecular sciences, 2022-04, Vol.23 (8), p.4392

2022

Volltextzugriff (PDF)

Tuberculosis: A persistent unpleasant neighbour of humans

Journal of infection and public health, 2021-04, Vol.14 (4), p.508-513

2021

Volltextzugriff (PDF)

Mycobacterium abscessus glycopeptidolipids inhibit macrophage apoptosis and bacterial spreading by targeting mitochondrial cyclophilin D

Cell death & disease, 2017-08, Vol.8 (8), p.e3012-e3012

2017

Volltextzugriff (PDF)

Isoegomaketone exhibits potential as a new Mycobacterium abscessus inhibitor

Frontiers in microbiology, 2024, Vol.15, p.1344914-1344914

2024

Volltextzugriff (PDF)

The autophagy-targeting compound V46 enhances antimicrobial responses to Mycobacteroides abscessus by activating transcription factor EB

Biomedicine & pharmacotherapy, 2024-10, Vol.179, p.117313, Article 117313

2024

Volltextzugriff (PDF)

Mycobacterium avium MAV2054 protein induces macrophage apoptosis by targeting mitochondria and reduces intracellular bacterial growth

Scientific reports, 2016-11, Vol.6 (1), p.37804-37804, Article 37804

2016

Volltextzugriff (PDF)

Comparison of Macrophage Immune Responses and Metabolic Reprogramming in Smooth and Rough Variant Infections of Mycobacterium mucogenicum

International journal of molecular sciences, 2022-02, Vol.23 (5), p.2488

2022

Volltextzugriff (PDF)

Dimethyl itaconate is effective in host-directed antimicrobial responses against mycobacterial infections through multifaceted innate immune pathways

Cell & bioscience, 2023-03, Vol.13 (1), p.49-49, Article 49

2023

Volltextzugriff (PDF)

Arginine-mediated gut microbiome remodeling promotes host pulmonary immune defense against nontuberculous mycobacterial infection

Gut microbes, 2022, Vol.14 (1), p.2073132

2022

Volltextzugriff (PDF)

Genetic stability of Mycobacterium abscessus during antibiotic treatment

Journal of global antimicrobial resistance., 2024-03, Vol.36, p.45-49

2024

Volltextzugriff (PDF)

Rufomycin Exhibits Dual Effects Against Mycobacterium abscessus Infection by Inducing Host Defense and Antimicrobial Activities

Frontiers in microbiology, 2021-08, Vol.12, p.695024-695024

2021

Volltextzugriff (PDF)

Sirtuin 3 is essential for host defense against Mycobacterium abscessus infection through regulation of mitochondrial homeostasis

Virulence, 2020-12, Vol.11 (1), p.1225-1239

2020

Volltextzugriff (PDF)

Differential Immune Responses and Underlying Mechanisms of Metabolic Reprogramming in Smooth and Rough Variants of Mycobacterium peregrinum Infections

Pathogens (Basel), 2023-12, Vol.12 (12), p.1446

2023

Volltextzugriff (PDF)

Mycobacterium avium MAV2052 protein induces apoptosis in murine macrophage cells through Toll-like receptor 4

Apoptosis (London), 2016-04, Vol.21 (4), p.459-472

2016

Volltextzugriff (PDF)

Mitofusin-2 boosts innate immunity through the maintenance of aerobic glycolysis and activation of xenophagy in mice

Communications biology, 2021-05, Vol.4 (1), p.548-548, Article 548

2021

Volltextzugriff (PDF)

Efficient Differentiation of Mycobacterium abscessus Complex Isolates to the Species Level by a Novel PCR-Based Variable-Number Tandem-Repeat Assay

Journal of Clinical Microbiology, 2011-03, Vol.49 (3), p.1107-1109

2011

Volltextzugriff (PDF)

Response

Chest, 2021-07, Vol.160 (1), p.e91

2021

Volltextzugriff (PDF)

Protocol of a Nationwide Observational Study among Patients with Nontuberculous Mycobacterium Pulmonary Disease in South Korea (NTM-KOREA)

Tuberculosis and respiratory diseases, 2020-04, Vol.83 (2), p.141

2020

Volltextzugriff (PDF)

Relationship between clarithromycin MICs and treatment responses in Mycobacterium avium complex pulmonary disease

Clinical infectious diseases, 2024-11

2024

Volltextzugriff (PDF)

Minimal Inhibitory Concentration of Clofazimine Among Clinical Isolates of Nontuberculous Mycobacteria and Its Impact on Treatment Outcome

Chest, 2021-02, Vol.159 (2), p.517-523

2021

Volltextzugriff (PDF)

Pan-Lineage Mycobacterium tuberculosis Reference Genome for Enhanced Molecular Diagnosis

DNA research, 2024-08, Vol.31 (4)

2024

Volltextzugriff (PDF)

Invasion of Mammalian Cells by Rough Variant of Mycobacterium abscessus

Journal of bacteriology and virology, 2016, Vol.46 (4), p.193

2016

Volltextzugriff (PDF)

The Impact of Trehalose Dimycolate on the Clinical Course of Mycobacterium avium Complex Pulmonary Disease

Annals of the American Thoracic Society, 2024-07, Vol.21 (7), p.1015-1021

2024

Volltextzugriff (PDF)

Novel Antibacterial Activity of Febuxostat, an FDA-Approved Antigout Drug against Mycobacterium tuberculosis Infection

Antimicrobial agents and chemotherapy, 2022-09, Vol.66 (9), p.e0076222

2022

Volltextzugriff (PDF)

Response

Chest, 2021-07, Vol.160 (1), p.e91-e91

2021

Volltextzugriff (PDF)

1 – 25 von 43

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(42)
Mit Volltextzugriff
(39)

Publikationsform

Artikel
(43)

Sprache

Englisch
(42)
Koreanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Aconitate Decarboxylase 1 Deficiency Exacerbates Mouse Colitis Induced by Dextran Sodium Sulfate

Tuberculosis: A persistent unpleasant neighbour of humans

Mycobacterium abscessus glycopeptidolipids inhibit macrophage apoptosis and bacterial spreading by targeting mitochondrial cyclophilin D

Isoegomaketone exhibits potential as a new Mycobacterium abscessus inhibitor

The autophagy-targeting compound V46 enhances antimicrobial responses to Mycobacteroides abscessus by activating transcription factor EB

Mycobacterium avium MAV2054 protein induces macrophage apoptosis by targeting mitochondria and reduces intracellular bacterial growth

Comparison of Macrophage Immune Responses and Metabolic Reprogramming in Smooth and Rough Variant Infections of Mycobacterium mucogenicum

Dimethyl itaconate is effective in host-directed antimicrobial responses against mycobacterial infections through multifaceted innate immune pathways

Arginine-mediated gut microbiome remodeling promotes host pulmonary immune defense against nontuberculous mycobacterial infection

Genetic stability of Mycobacterium abscessus during antibiotic treatment

Rufomycin Exhibits Dual Effects Against Mycobacterium abscessus Infection by Inducing Host Defense and Antimicrobial Activities

Sirtuin 3 is essential for host defense against Mycobacterium abscessus infection through regulation of mitochondrial homeostasis

Differential Immune Responses and Underlying Mechanisms of Metabolic Reprogramming in Smooth and Rough Variants of Mycobacterium peregrinum Infections

Mycobacterium avium MAV2052 protein induces apoptosis in murine macrophage cells through Toll-like receptor 4

Mitofusin-2 boosts innate immunity through the maintenance of aerobic glycolysis and activation of xenophagy in mice

Efficient Differentiation of Mycobacterium abscessus Complex Isolates to the Species Level by a Novel PCR-Based Variable-Number Tandem-Repeat Assay

Response

Protocol of a Nationwide Observational Study among Patients with Nontuberculous Mycobacterium Pulmonary Disease in South Korea (NTM-KOREA)

Relationship between clarithromycin MICs and treatment responses in Mycobacterium avium complex pulmonary disease

Minimal Inhibitory Concentration of Clofazimine Among Clinical Isolates of Nontuberculous Mycobacteria and Its Impact on Treatment Outcome

Pan-Lineage Mycobacterium tuberculosis Reference Genome for Enhanced Molecular Diagnosis

Invasion of Mammalian Cells by Rough Variant of Mycobacterium abscessus

The Impact of Trehalose Dimycolate on the Clinical Course of Mycobacterium avium Complex Pulmonary Disease

Novel Antibacterial Activity of Febuxostat, an FDA-Approved Antigout Drug against Mycobacterium tuberculosis Infection

Response

Suchergebnisse filtern